0001209191-16-103640.txt : 20160301
0001209191-16-103640.hdr.sgml : 20160301
20160301103346
ACCESSION NUMBER: 0001209191-16-103640
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160224
FILED AS OF DATE: 20160301
DATE AS OF CHANGE: 20160301
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AERIE PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001337553
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 203109565
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 7020 KIT CREEK ROAD
STREET 2: SUITE 270
CITY: RESEARCH TRIANGLE PARK
STATE: NC
ZIP: 27709
BUSINESS PHONE: 919-313-9650
MAIL ADDRESS:
STREET 1: 7020 KIT CREEK ROAD
STREET 2: SUITE 270
CITY: RESEARCH TRIANGLE PARK
STATE: NC
ZIP: 27709
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: ANIDO VICENTE JR
CENTRAL INDEX KEY: 0001207633
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36152
FILM NUMBER: 161471613
MAIL ADDRESS:
STREET 1: 1621 BAYSIDE DR
CITY: CORONA DEL MAR
STATE: CA
ZIP: 92625
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2016-02-24
0
0001337553
AERIE PHARMACEUTICALS INC
AERI
0001207633
ANIDO VICENTE JR
C/O AERIE PHARMACEUTICALS, INC.,
2030 MAIN STREET, SUITE 1500
IRVINE
CA
92614
1
1
0
0
Chief Executive Officer
Common Stock
2016-02-24
4
A
0
25085
0.00
A
75273
D
Stock Option (right to buy)
16.69
2016-02-24
4
A
0
150504
0.00
A
2026-02-24
Common Stock
150504
150504
D
These shares of Common Stock are scheduled to vest, subject to the reporting person's continued employment with the issuer through the applicable vesting date, in four equal annual installments on the anniversary of February 24, 2016.
This option is scheduled to vest, subject to the reporting person's continued employment with the issuer through the applicable vesting date, ratably on each of the 48 monthly anniversaries of February 24, 2016.
/s/ Richard J. Rubino, Attorney-in-Fact for Vicente Anido, Jr.
2016-02-29